Cipro Suspension/ Drops
Product Images NDC 76420-273

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cipro (NDC 76420-273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ciprofloxacin Chemical Structure (Ciprohc 01)

FDA Label Image

Hydrocortisone Chemical Structure (Ciprohc 02)

FDA Label Image

Principal Display Panel Ndc 0078-0855-26 Cipro® Hc Otic (ciprofloxacin 0.2% Hci And Hydrocortisone 1% Otic Suspension) Not For Ophthalmic Or Oral Use Rx O (Ciprohc 03)

Principal Display Panel									Ndc 0078-0855-26									Cipro® Hc Otic									(ciprofloxacin 0.2% Hci And Hydrocortisone 1% Otic Suspension)									Not For Ophthalmic Or Oral Use									Rx O (Ciprohc 03)
The text is a description of the Cipro HC Otic medication, including details such as the quantity, batch number, and cautionary statements. The medication is distributed by Novartis Pharmaceuticals Corp. and is available only by prescription. The text also includes the drug status and storage instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.